Frederic Bernard, based in Germany, is currently a Global Program Head Neurology and Immunology, Mavenclad and Cladribine at Merck KGaA, Darmstadt, Germany. Frederic Bernard brings experience from previous roles at Merck KGaA, Darmstadt, Germany and EMD Serono, Inc.. Frederic Bernard holds a 2000 - 2003 PhD in Neuroscience @ University of Strasbourg. With a robust skill set that includes In Vivo, Drug Discovery, Pharmacology, Animal Models, Neurodegenerative Diseases and more. Frederic Bernard has 3 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.